國壽/太保/新華保險AH續升2%-5%內地27家險企購科創板新股
內地科創板落實開市日期，首批25家公司將於7月22日集中上市，目前科創板新股正在密集申購期，7月8-12日，將有21家公司進行網上網下申購，本周三(10日)為最多一天達9家，對投資者來說，將迎來科創板「打新」的黃金周。截至昨日止，內地共有27家保險公司認購科創板「打新」，其中16家險企出現在杭可科技、天准科技、華興源創及睿創微納等4家首發科創公司配售名單中，合計獲得配售金額6,548.36萬元人民幣，其中中國平安(02318.HK)及中國太保(02601.HK)旗下平安養老及長江養老獲配金額較高，均超千萬元人民幣。
內險股今天普遍跑贏，太保AH均三連漲，H股高見31.8元，回補5月6日大部分下跌裂口(31.85-30.5元)，現造31.75元，續升4.3%，成交增至2,443萬股，創逾一個月高，涉資7.34億元；太保A股高見38.08元人民幣，創逾兩個月高，收37.67元人民幣，續升4%，成交增至4,565萬股，涉資逾17億人民幣。
國壽H股曾重越百天線(20.24元)，最高見20.4元，創兩個月高，現造20.25元，續升2.1%；其A股高見31.05元人民幣，創近兩個半月高，收30.67元人民幣，續升5%，成交增至3,154萬股，涉資逾9.5億元人民幣。
新華保險(01336.HK)重越10天及20天線，最高見38.15元，現造37.85元，續升2%；其A股高見55.35元人民幣，收54.76元人民幣，續升3.1%。
中國人保(01339.HK)A股高見9.37元人民幣，收9.25元人民幣，續升2.6%；已升兩天的H股僅反覆續升0.3%報3.19元。擁有銀行業務的中國平安H股高見95.25元，現造94.65元，續升0.6%；其A股高見89.47元人民幣，收88.75元人民幣，續升0.9%。
恆指及國指現造28,489及10,810，均續升0.2%；滬指收2,930，反覆續彈0.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
